Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Ibrutinib

Lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kim PM, et al. Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL). Cold Spring Harbor Molecular Case Studies 9: 1-15, Jan 2023. Available from: URL: https://dx.doi.org/10.1101/mcs.a006283 Kim PM, et al. Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL). Cold Spring Harbor Molecular Case Studies 9: 1-15, Jan 2023. Available from: URL: https://​dx.​doi.​org/​10.​1101/​mcs.​a006283
Metadaten
Titel
Ibrutinib
Lack of efficacy
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57519-7

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Dupilumab

Case report

Mannitol

Case report

Lidocaine

Case report

Prednisone